CCA (disodium 4-chloro-2,2'-iminodibenzoate) inhibits progression of human T cell proliferation triggered by PHA

Clinical Immunology and Immunopathology
K KatagiriT Yoshida

Abstract

The effect of the anti-rheumatic drug CCA (disodium 4-chloro-2,2'-iminodibenzoate) on the proliferation of T cells activated by PHA was examined. Cell cycle analysis showed that CCA blocked the transition of the cells from G1 to S (progression), but had little effect on the G0----G1 transition (initiation). CCA had no significant effect on IL-2 receptor expression, an early G1 event, but did inhibit transferrin receptor expression, a late G1 event. CCA did not inhibit IL-2 production by PHA-activated T cells, but did block IFN-gamma production at 72 hr after the stimulation. CCA failed to inhibit c-myc mRNA induction, but did delay the decrease in c-myc mRNA levels that normally occurs with the onset of DNA synthesis. These results indicate that CCA inhibits the progression, but not initiation, of human T cell proliferation.

References

May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G AnfossiB Calabretta
Jun 1, 1985·The Journal of Experimental Medicine·M KrönkeW C Greene
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J C ReedR G Hoover
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J C ReedR G Hoover
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P S Thomas
Jun 22, 1984·Science·D A Cantrell, K A Smith

❮ Previous
Next ❯

Citations

Apr 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·D R HaynesB Vernon-Roberts

❮ Previous
Next ❯

Related Concepts

Related Feeds